Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Swanton

Showing results (281-290 of 440) with videos related to

Pageof 44
Sort By:
Nature Communications|August 10, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clonesA M Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog, et al.
Cancer Cell|January 11, 2017
BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal CancerCarlos López-García, Laurent Sansregret, Enric Domingo, et al.
Lancet (London, England)|July 1, 2021
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOCEmma C Wall, Mary Wu, Ruth Harvey, et al.
The Lancet. Oncology|July 24, 2020
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling studyAmit Sud, Bethany Torr, Michael E Jones, et al.
Science Advances|November 1, 2024
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responsesMegan Cole, Panayiotis Anastasiou, Claudia Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Decoding biological age from face photographs using deep learningOsbert Zalay, Dennis Bontempi, Danielle S Bitterman, et al.
Nature Communications|October 30, 2025
BRCA2 deficiency and replication stress drive APOBEC3-Mediated genomic instabilityKathy Situ, Haohui Duan, Stephen K Godin, et al.
The Lancet. Oncology|September 4, 2025
Establishing the China-UK Cancer Prevention and Control AllianceJun Ma, David Kerr, Yuankai Shi, et al.
NPJ Precision Oncology|March 12, 2025
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancerGary Middleton, Helen L Robbins, Peter Fletcher, et al.
CA: a Cancer Journal for Clinicians|February 6, 2019
Artificial intelligence in cancer imaging: Clinical challenges and applicationsWenya Linda Bi, Ahmed Hosny, Matthew B Schabath, et al.
Pageof 44

Showing results (281-290 of 440) with videos related to

Sort By:
Pageof 44
Nature Communications|August 10, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clonesA M Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog, et al.
Cancer Cell|January 11, 2017
BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal CancerCarlos López-García, Laurent Sansregret, Enric Domingo, et al.
Lancet (London, England)|July 1, 2021
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOCEmma C Wall, Mary Wu, Ruth Harvey, et al.
The Lancet. Oncology|July 24, 2020
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling studyAmit Sud, Bethany Torr, Michael E Jones, et al.
Science Advances|November 1, 2024
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responsesMegan Cole, Panayiotis Anastasiou, Claudia Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Decoding biological age from face photographs using deep learningOsbert Zalay, Dennis Bontempi, Danielle S Bitterman, et al.
Nature Communications|October 30, 2025
BRCA2 deficiency and replication stress drive APOBEC3-Mediated genomic instabilityKathy Situ, Haohui Duan, Stephen K Godin, et al.
The Lancet. Oncology|September 4, 2025
Establishing the China-UK Cancer Prevention and Control AllianceJun Ma, David Kerr, Yuankai Shi, et al.
NPJ Precision Oncology|March 12, 2025
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancerGary Middleton, Helen L Robbins, Peter Fletcher, et al.
CA: a Cancer Journal for Clinicians|February 6, 2019
Artificial intelligence in cancer imaging: Clinical challenges and applicationsWenya Linda Bi, Ahmed Hosny, Matthew B Schabath, et al.
Pageof 44